| ISIN | IE00B8431S50 |
|---|---|
| Valor Number | 20458045 |
| Bloomberg Global ID | EISEVCA ID |
| Fund Name | E.I. Sturdza Funds plc - Strategic Europe Quality Fund A CHF |
| Fund Provider |
E.I. Sturdza Strategic Management Limited
Phone: +44 1481 722322 E-Mail: info@ericsturdza.com Web: www.ericsturdza.com |
| Fund Provider | E.I. Sturdza Strategic Management Limited |
| Representative in Switzerland |
CACEIS (Switzerland) SA Nyon Phone: +41 22 360 94 00 |
| Distributor(s) |
Eric Sturdza Asset Management SA Geneva |
| Asset Class | Equities |
| EFC Category | Equity Europe |
| Distribution Policy | Accumulation |
| Home Country | Ireland |
| Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
| Redemption Condition | The fund charges a transaction fee (contribution towards covering expenses incurred in the sale of assets) |
| Investment Strategy *** | The investment objective of the Fund is to achieve long term capital growth. |
| Peculiarities |
| Current Price * | 211.24 CHF | 19.11.2025 |
|---|---|---|
| Previous Price * | 211.29 CHF | 18.11.2025 |
| 52 Week High * | 230.58 CHF | 17.02.2025 |
| 52 Week Low * | 188.56 CHF | 07.04.2025 |
| NAV * | 211.24 CHF | 19.11.2025 |
| Issue Price * | ||
| Redemption Price * | 211.24 CHF | 19.11.2025 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 88,071,220 | |
| Unit/Share Assets *** | 1,572,107 | |
| Trading Information SIX | ||
| YTD Performance | -1.17% |
31.12.2024 - 19.11.2025
31.12.2024 19.11.2025 |
|---|---|---|
| 1 month | -3.68% |
20.10.2025 - 19.11.2025
20.10.2025 19.11.2025 |
| 3 months | -3.30% |
19.08.2025 - 19.11.2025
19.08.2025 19.11.2025 |
| 6 months | -3.34% |
19.05.2025 - 19.11.2025
19.05.2025 19.11.2025 |
| 1 year | +1.11% |
19.11.2024 - 19.11.2025
19.11.2024 19.11.2025 |
| 2 years | +13.54% |
20.11.2023 - 19.11.2025
20.11.2023 19.11.2025 |
| 3 years | +16.13% |
21.11.2022 - 19.11.2025
21.11.2022 19.11.2025 |
| 5 years | +15.87% |
19.11.2020 - 19.11.2025
19.11.2020 19.11.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Rolls-Royce Holdings PLC | 5.48% | |
|---|---|---|
| Essilorluxottica | 4.85% | |
| Galderma Group AG Registered Shares | 4.40% | |
| Bureau Veritas SA | 4.38% | |
| Danone SA | 4.18% | |
| AstraZeneca PLC | 4.15% | |
| MTU Aero Engines AG | 4.03% | |
| Compagnie Financiere Richemont SA Class A | 3.98% | |
| Commerzbank AG | 3.59% | |
| Amundi Euro Stoxx Banks ETF Acc | 3.28% | |
| Last data update | 31.10.2025 | |
| TER *** | 1.75% |
|---|---|
| TER date *** | 30.06.2025 |
| Performance Fee *** | 10.00% |
| PTR | |
| Max. Management Fee *** | 1.50% |
| Ongoing Charges *** | 1.75% |
|
SRRI ***
|
|
| SRRI date *** | 31.10.2025 |